Bristol-Myers Squibb To Spin-Off Zimmer, Inc.
23-Feb-2001
Divestiture of Zimmer is an element in Bristol-Myers Squibb’s stated strategy of focusing attention and resources on its Medicines businesses.
Bristol-Myers Squibb expects to establish Zimmer as an independent publicly traded company by the end of the third quarter of 2001.
Organizations
Bristol-Myers Squibb
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.